.jpg "Shiew-Mei Huang, PhD photo")
Deputy Office Director, OCP/OTS/CDER/FDA
US Food and Drug Administration
Dr. Huang is Deputy Director, Office of Clinical Pharmacology, Center for Drug Evaluation and Research (CDER), FDA. She received her B.S. in Pharmacy from National Taiwan University, School of Pharmacy in 1975 and her Ph.D. from University of Illinois, Medical Center in Pharmacokinetics and Biopharmaceutics in 1981. She had 15+ year drug development experience (Ortho pharmaceutical Corp. and Dupont-Merck Pharmaceutical Company) before joining the FDA in 1996.
She has published over 180 peer-reviewed articles and book chapters focusing on topics in clinical pharmacology, drug metabolism/transport interactions, physiologically based pharmacokinetic modeling and pharmacogenomics areas and is a frequent speaker at national and international meetings and workshops. Dr. Huang is an associate editor for the journal “Clinical Pharmacology and Therapeutics” and on the editorial boards of several other journals including Expert Review in Clinical Pharmacology, Expert Opinion- Pharmacotherapy; Pharmacogenomics. She has received many awards, including an FDA Outstanding Achievement Award, FDA Clear Communication Award, and FDA Distinguished Service Award. Dr. Huang is a fellow of AAPS (American Association of Pharmaceutical Scientists) and JSSX (Japanese Society of the Study of Xenobiotics) and a diplomate of the American Board of Clinical Pharmacology. She is an Adjunct Professor at the School of Pharmacy, University of Maryland and has been a faculty member of an elective course on pharmacogenomics since 2008. She was the President (2009-2010) of the American Society for Clinical Pharmacology and Therapeutics (ASCPT). She has received prestigious ASCPT Awards: “Gary Neil Prize for Innovation in Drug Development” in March 2014 and “Henry Elliott Distinguished Service Award” in March 2016.
Disclosure information not submitted.
Friday, March 18, 2022
1:15 PM – 2:15 PM ET
.png)